Brief: Design Therapeutics Appoints Jae Kim As Chief Medical Officer
01/02/2022 22:19
Feb 1 (Reuters) - Design Therapeutics Inc DSGN.O :
* DESIGN THERAPEUTICS APPOINTS DRUG DEVELOPMENT EXPERT, JAE
KIM,
M.D., AS CHIEF MEDICAL OFFICER
Source text for Eikon: ID:nGNX51VL56
Further company coverage: DSGN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Design Therapeutics
See all newsDesign Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Design Therapeutics Q2 net loss narrower than expected
Brief: Design Therapeutics Q2 Basic EPS USD -0.32
Design Therapeutics Inc expected to post a loss of 34 cents a share - Earnings Preview
Brief: Design Therapeutics Announces Initiation Of Patient Dosing In Phase 1 Multiple Ascending Dose Trial Of Dt-818 For Myotonic Dystrophy Type-1